Skip to main content

Market Overview

Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

Share:
Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

Eli Lilly And Co (NYSE:LLY) experienced a 1.37% increase in pre-market trading on Wednesday, as per Benzinga Pro. This uptick occurs as the company gears up to announce its third-quarter earnings. Wall Street analysts are forecasting earnings per share of $1.45 and revenues of $12.1 billion.

What Happened: Eli Lilly has established itself as a significant player in the weight loss drug market, with its products Mounjaro and Zepbound generating over $4 billion in the last quarter.

The stock has seen remarkable growth, surging 58.31% over the past year and 51.23% year-to-date, with shares nearing $900. This increase from around $250 two years ago has led to speculation about a potential stock split, which could make shares more accessible to a broader range of investors.

See Also: Bitcoin Hovers Around New All-Time High, Ethereum, Dogecoin Surge As Crypto Market In Turbo Mode: Top Analyst Says, ‘History In The Making’

Why It Matters: Eli Lilly is on the verge of becoming the first trillion-dollar pharmaceutical company, driven by the success of its weight loss drugs. The company’s market cap was $796.4 billion, with an enterprise value of $821.9 billion as of early October. The stock has nearly doubled since May 2022, outperforming both the S&P 500 and NASDAQ following FDA approval for Mounjaro as a treatment for type 2 diabetes.

Additionally, Eli Lilly has intensified its legal efforts against compounders producing unauthorized copies of its weight loss drugs. The FDA recently declared the shortage of Eli Lilly’s tirzepatide injection resolved, reminding compounders of legal restrictions on replicating FDA-approved medications.

Read Next:

Image via Shutterstock

This story was generated using Benzinga Neuro and edited by Pooja Rajkumari

 

Related Articles (LLY)

View Comments and Join the Discussion!

Posted-In: Mounjaro Pooja Rajkumari stock split Stories That MatterNews Pre-Market Outlook Markets General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com